Novartis

Dermatology

Cosentyx^® (secukinumab) is a prescription drug for treating moderate to severe psoriasis.

It is one of the major launches of Novartis in 2015 – 2016.  It is a human monoclonal antibody that binds to the protein interleukin (IL)-17A,^[1] which means that it is the fastest because it takes the “shortest way”.

Like Google Maps would do. We created Cosentyx Maps. The campaign had a massive roll-out with many digital, training, print, you name it, materials…

Awarded with best integrated campaign to prescriptor 2016.

Strategy // Creativity // Medical Writing // Audiovisual // Digital // Events